Diseases, Conditions, Syndromes

SARS-CoV-2 antibodies provide lasting immunity

One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long.

Immunology

Cells sacrifice themselves to boost immune response to viruses

Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection. New research appearing in the journal Nature Immunology describes how different cells in the immune ...

Diseases, Conditions, Syndromes

Immune cell activation in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

Diseases, Conditions, Syndromes

Study reveals most effective drugs for common type of neuropathic pain

More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information to guide a physician's ...

page 1 from 12